Compound ID | 2807
Class: Small molecule antibacterial agent
| Details of activity: | Active against monodrug-resistant and -susceptible Mycobacterium tuberculosis and nontuberculous mycobacteria; MmpL3 (mycolate flippase) inhibitor |
| Description: | Synthetic compound; derived from previously identified MmpL3 inhibitor HC2099; efficacious in treating acute Mycobacterium tuberculosis infection in vivo in mice but not in chronic infection |
| Institute where first reported: | Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, USA |
| Year first mentioned: | 2023 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/488953618 |
| Citations: |
|